Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015, Article ID 972083, 9 pages
http://dx.doi.org/10.1155/2015/972083
Research Article

The Adjuvant Activity of Epimedium Polysaccharide-Propolis Flavone Liposome on Enhancing Immune Responses to Inactivated Porcine Circovirus Vaccine in Mice

1College of Veterinary Medicine, Northwest A&F University, Yangling, Shaanxi 712100, China
2College of Animal Science, Yangtze University, Jingzhou 434023, China
3Medicinal Engineering Department of Henan University of Animal Husbandry and Economy, Zhengzhou, Henan 450011, China

Received 4 August 2015; Accepted 1 October 2015

Academic Editor: Kuttulebbai N. S. Sirajudeen

Copyright © 2015 Yunpeng Fan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Z. Yin and J. H. Liu, Animal Virology, Science Press, Beijing, China, 1997.
  2. J. Segales, C. Piñeiro, F. Lampreave et al., “Haptoglobin and pig-major acute protein are increased in pigs with postweaning multisystemic wasting syndrome (PMWS),” Veterinary Research, vol. 35, no. 3, pp. 275–282, 2004. View at Publisher · View at Google Scholar
  3. J. A. Ellis, A. Bratanich, E. G. Clark et al., “Coinfection by porcine circoviruses and porcine parvovirus in pigs with naturally acquired postweaning multisystemic wasting syndrome,” Journal of Veterinary Diagnostic Investigation, vol. 12, no. 1, pp. 21–27, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. J. C. S. Harding, “The clinical expression and emergence of porcine circovirus 2,” Veterinary Microbiology, vol. 98, no. 2, pp. 131–135, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. C. Chae, “A review of porcine circovirus 2-associated syndromes and diseases,” Veterinary Journal, vol. 169, no. 3, pp. 326–336, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Zhao, A. Seth, N. Wibowo et al., “Nanoparticle vaccines,” Vaccine, vol. 32, no. 3, pp. 327–337, 2014. View at Google Scholar
  7. J. C. Aguilar and E. G. Rodríguez, “Vaccine adjuvants revisited,” Vaccine, vol. 25, no. 19, pp. 3752–3762, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. S. G. Reed, S. Bertholet, R. N. Coler, and M. Friede, “New horizons in adjuvants for vaccine development,” Trends in Immunology, vol. 30, no. 1, pp. 23–32, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. A. M. Harandi, J. Brewer, and V. Schijns, “Conference scene: Recent advancements in immunopotentiators for modern vaccines,” Immunotherapy, vol. 3, no. 11, pp. 1297–1301, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. P. V. Licciardi and J. R. Underwood, “Plant-derived medicines: a novel class of immunological adjuvants,” International Immunopharmacology, vol. 11, no. 3, pp. 390–398, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Nada, Č. Miodrag, B. Aleksandar, and D. K. Zvezdana, “Immunomodulatory effects of the methanolic extract of Epimedium alpinum in vitro,” Fitoterapia, vol. 77, no. 7-8, pp. 561–567, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. Z. Q. Shen and Y. F. Yang, “Propolis, a new adjuvant,” Chinese Journal of Preventive Veterinary Medicine, vol. 5, pp. 55–57, 1989. View at Google Scholar
  13. Y. P. Fan, Y. L. Hu, D. Y. Wang et al., “Epimedium polysaccharide and propolis flavone can synergistically stimulate lymphocyte proliferation in vitro and enhance the immune responses to ND vaccine in chickens,” International Journal of Biological Macromolecules, vol. 47, no. 2, pp. 87–92, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. P. Fan, D. Y. Wang, J. G. Liu et al., “Adjuvanticity of epimedium polysaccharide-propolis flavone on inactivated vaccines against AI and ND virus,” International Journal of Biological Macromolecules, vol. 51, no. 5, pp. 1028–1032, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. P. Patil and S. Jadhav, “Novel methods for liposome preparation,” Chemistry and Physics of Lipids, vol. 177, pp. 8–18, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Yuan, J. G. Liu, Y. L. Hu et al., “The immunological activity of propolis flavonoids liposome on the immune response against ND vaccine,” International Journal of Biological Macromolecules, vol. 51, no. 4, pp. 400–405, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Gao, Y. P. Fan, D. Y. Wang et al., “Optimization on preparation condition of epimedium polysaccharide liposome and evaluation of its adjuvant activity,” International Journal of Biological Macromolecules, vol. 50, no. 1, pp. 207–213, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. P. Fan, D. Y. Wang, Y. L. Hu et al., “Liposome and epimedium polysaccharide-propolis flavone can synergistically enhance immune effect of vaccine,” International Journal of Biological Macromolecules, vol. 50, no. 1, pp. 125–130, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. P. Fan, J. G. Liu, D. Y. Wang et al., “The preparation optimization and immune effect of epimedium polysaccharide-propolis flavone liposome,” Carbohydrate Polymers, vol. 94, no. 1, pp. 24–30, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. B. Q. Liu, Veterinary Biology Produce, Chinese Agricultural Press, Beijing, China, 1999.
  21. Y. Huang, C. H. Wu, Z. G. Liu et al., “Optimization on preparation conditions of Rehmannia glutinosa polysaccharide liposome and its immunological activity,” Carbohydrate Polymers, vol. 104, no. 1, pp. 118–126, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. M. M. O. Thekisoe, P. A. Mbati, and S. P. R. Bisschop, “Different approaches to the vaccination of free ranging village chickens against Newcastle disease in Qwa-Qwa, South Africa,” Veterinary Microbiology, vol. 101, no. 1, pp. 23–30, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. K. J. Livak and T. D. Schmittgen, “Analysis of relative gene expression data using real-time quantitative PCR and the 2-[delta][delta] CT method,” Methods, vol. 25, no. 4, pp. 402–408, 2001. View at Google Scholar
  24. H.-X. Sun, H. Wang, H.-S. Xu, and Y. Ni, “Novel polysaccharide adjuvant from the roots of Actinidia eriantha with dual Th1 and Th2 potentiating activity,” Vaccine, vol. 27, no. 30, pp. 3984–3991, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. H. X. Sun, L. Q. Chen, J. Wang, K. Wang, and J. Zhou, “Structure-function relationship of the saponins from the roots of Platycodon grandiflorum for hemolytic and adjuvant activity,” International Immunopharmacology, vol. 11, no. 12, pp. 2047–2056, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. P. Fan, X. Ma, J. Zhang et al., “Ophiopogon polysaccharide liposome can enhance the non-specific and specific immune response in chickens,” Carbohydrate Polymers, vol. 119, pp. 219–227, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. Yu, D. Wang, S. Abula et al., “The immunological adjuvant activity of gypenosides liposome against Newcastle disease vaccine,” International Journal of Biological Macromolecules, vol. 60, pp. 116–121, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. A. S. McKee, M. K. L. MacLeod, J. W. Kappler, and P. Marrack, “Immune mechanisms of protection: can adjuvants rise to the challenge?” BMC Biology, vol. 8, article 34, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. X. Su, Z. Pei, and S. Hu, “Ginsenoside Re as an adjuvant to enhance the immune response to the inactivated rabies virus vaccine in mice,” International Immunopharmacology, vol. 20, no. 2, pp. 283–289, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Zhu and W. E. Paul, “CD4 T cells: fates, functions, and faults,” Blood, vol. 112, no. 5, pp. 1557–1569, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. D. M. Brown, “Cytolytic CD4 cells: direct mediators in infectious disease and malignancy,” Cellular Immunology, vol. 262, no. 2, pp. 89–95, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. S. F. Li, Y. Li, J. D. Zhang, C. S. Zheng, and F. Sun, “Effects of rice bran polysaccharide on CD4+ T cells and CD8+ T cells in chickens,” Animal Husbandry and Veterinary Medicine, vol. 4, pp. 59–62, 2009. View at Google Scholar
  33. D. M. Brown, C. Kamperschroer, A. M. Dilzer, D. M. Roberts, and S. L. Swain, “IL-2 and antigen dose differentially regulate perforin- and FasL-mediated cytolytic activity in antigen specific CD4+ T cells,” Cellular Immunology, vol. 257, no. 1-2, pp. 69–79, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. J. A. Levy, “The search for the CD8+ cell anti-HIV factor (CAF),” Trends in Immunology, vol. 24, no. 12, pp. 628–632, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. X. J. Zhao, Y. P. Fan, D. Y. Wang et al., “Immunological adjuvant efficacy of glycyrrhetinic acid liposome against Newcastle disease vaccine,” Vaccine, vol. 29, no. 52, pp. 9611–9617, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. J. L. Meng, C. P. Feng, H. Y. Cheng, M. C. Chang, J. Wang, and H. J. Li, “Effects of Agaricus blazei murrill polysaccharide on the mRNA expression of the cytokines in rats,” Journal of Chinese Institute of Food Science and Technology, vol. 12, no. 4, pp. 19–24, 2012. View at Google Scholar
  37. Y. Huang, C. M. Jiang, Y. L. Hu et al., “Immunoenhancement effect of rehmannia glutinosa polysaccharide on lymphocyte proliferation and dendritic cell,” Carbohydrate Polymers, vol. 96, no. 2, pp. 516–521, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. A. S. McKee, M. W. Munks, and P. Marrack, “How do adjuvants work? important considerations for new generation adjuvants,” Immunity, vol. 27, no. 5, pp. 687–690, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. N. Matsushita, A. Aruga, Y. Kobayashi, K. Tanigawa, and M. Yamamoto, “Separation methods of T cells, natural killer, and dendritic cells from peripheral blood of cancer patients using interleukin-2 and functional analysis of natural killer cells after separation,” Immunopharmacology and Immunotoxicology, vol. 29, no. 1, pp. 31–47, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Ohira, H. Ohdan, H. Mitsuta et al., “Adoptive transfer of TRAIL-expressing natural killer cells prevents recurrence of hepatocellular carcinoma after partial hepatectomy,” Transplantation, vol. 82, no. 12, pp. 1712–1719, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. H. X. Sun, S. W. He, and M. H. Shi, “Adjuvant-active fraction from Albizia julibrissin saponins improves immune responses by inducing cytokine and chemokine at the site of injection,” International Immunopharmacology, vol. 22, no. 2, pp. 346–355, 2014. View at Publisher · View at Google Scholar · View at Scopus
  42. L. Yuan, L. Wu, J. Chen, Q. Wu, and S. H. Hu, “Paclitaxel acts as an adjuvant to promote both Th1 and Th2 immune responses induced by ovalbumin in mice,” Vaccine, vol. 28, no. 27, pp. 4402–4410, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. S. Kamstrup, R. San Martin, A. Doberti, H. Grande, and K. Dalsgaard, “Preparation and characterisation of quillaja saponin with less heterogeneity than Quil-A,” Vaccine, vol. 18, no. 21, pp. 2244–2249, 2000. View at Publisher · View at Google Scholar · View at Scopus
  44. X. M. Song, L. M. Zang, and S. H. Hu, “Amplified immune response by ginsenoside-based nanoparticles (ginsomes),” Vaccine, vol. 27, no. 17, pp. 2306–2311, 2009. View at Publisher · View at Google Scholar · View at Scopus